Client
- Location
- New Jersey · United States of America
Registrant
- Firm
- MICHAEL POLLARD
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
3 issuesHealth Issues
HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Afforadable Generics Act; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S. 3505 and S. 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2008; all aspects HR 2914 and S. 2990 - Medicare IVIG Acces Act of 2007; all aspects HR. 3800 - Promoting Health Information Technology Act; all aspects HR 5629 - Pathway for Biosimilars Act; all aspects HR 6357 - Protecting Records, Optimimizing Treatment and Easing Communications through Healthcare Technology (PRO[TECH]HIT) Act of 2008; all aspects HR 6898 - Health-e-Information Technology Act of 2008; all aspects S 976 - Genomics and Personlized Medicine Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S 1814 - Health Information Privacy and Security Act; all aspects
LobbyistsMICHAEL POLLARD
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · Health & Human Services, Dept of (HHS) · Centers For Medicare and Medicaid Services (CMS) · Drug Enforcement Administration (DEA)
Medicare/Medicaid
Medicare Part D, Antitrust Exemption for Independent Pharmacies, IVIG Payments, Medicare Demonstration Projects for Durable Medical Equipment HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 2567 and S. 3505 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2914 and S 2990 - Medicaer IVIG Access Act of 2008; all aspects
LobbyistsMICHAEL POLLARD
